跳至主要内容
临床试验/CTRI/2020/09/027594
CTRI/2020/09/027594已完成1 期

An Open-Label, Randomized, Active Controlled, Phase I Clinical Study to Assess the Safety and Tolerability of SII Yellow Fever Vaccine in Healthy Adults.

Serum Institute of India Pvt Ltd0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Healthy adult male or non-pregnant female participants aged between 18-45 years.
  • 2.Normal health as determined by medical history, clinical examination and laboratory assessment.
  • 3.Participants willing to adhere to the protocol requirements and to provide written informed consent
  • 4.Availability for clinical follow up through period of the study.
  • 5.Female participants with negative pregnancy test during screening and prior to vaccine administration and agree to avoid pregnancy during participation in the study.

排除标准

  • 1.Fever or any acute infection at time of immunization(Temporary exclusion criteria).
  • 2.A known hypersensitivity to any of the vaccine components or history of a life-threatening reaction to a vaccine containing the same substances.
  • 3.Travel to a YF endemic area [Africa or South America including participants who plan to travel to these areas prior to completion of the study].
  • 4.Known history of infection with YF, dengue fever, TBE, JE, or West e Virus (WNV)
  • 5. Positive ELISA for YF virus antibodies.
  • 6. Woman who is pregnant or breast feeding.

研究者

相似试验

招募中
1 期
Setrusumab vs Bisphosphonates in Pediatric Subjects with Osteogenesis ImperfectaMedDRA version: 20.0Level: PTClassification code: 10031243Term: Osteogenesis imperfecta Class: 100000004850osteogenesis imperfecta
CTIS2023-504196-24-00ltragenyx Pharmaceutical Inc.68
进行中(未招募)
1 期
An Investigational Immuno-therapy Study to Compare Relatlimab in Combination with Nivolumab with Various Standard-of-Care Therapies in Patients with Gastric Cancer or Gastroesophageal Junction AdenocarcinomaRecurrent, Locally Advanced, or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction (GEJ) AdenocarcinomaMedDRA version: 20.1 Level: PT Classification code 10017758 Term: Gastric cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: LLT Classification code 10056267 Term: Gastroesophageal cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2018-001070-20-ESBristol-Myers Squibb International Corporation2,180
已完成
1 期
A clinical study to assess the safety and immune response of rabies vaccine of Serum Institute of India Ltd (SIIL).
CTRI/2011/07/001903Serum Institute of India Ltd60
已完成
2 期
A study of Purified Vero Rabies vaccine for prophylaxis in patients with rabies exposure
CTRI/2012/11/003135Serum Institute of India Limited181
尚未招募
2 期
Effect of Herbal medicine, Allopathic medicine and lifestyle modification on newly diagnosed diabetes.
CTRI/2023/09/057282Maharashtra University of health sciences Nashik